You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Doxorubicin and cyclophosphamide

Showing 1 - 25 of 3,478
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

Not yet recruiting
  • Lymphoblastic Leukemia in Children
  • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
  • +7 more
  • (no location specified)
Oct 24, 2023

Breast Cancer Invasive, Hormone-receptor-positive Breast Cancer, HER2 Low Breast Carcinoma Trial in Guangzhou (Pyrotinib,

Not yet recruiting
  • Breast Cancer Invasive
  • +3 more
  • Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 17, 2023

Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)

Not yet recruiting
  • Breast Cancer
  • Nanoxel M
  • +3 more
  • (no location specified)
Jan 20, 2022

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Triple Negative Breast Cancer Trial in Zhengzhou (Docetaxel +doxorubicin+ cyclophosphamide, Docetaxel +Cisplatin)

Recruiting
  • Triple Negative Breast Cancer
  • Docetaxel +doxorubicin+ cyclophosphamide
  • Docetaxel +Cisplatin
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 18, 2022

Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

Active, not recruiting
  • Ann Arbor Stage III Non-Hodgkin Lymphoma
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 28, 2023

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022

Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)

Not yet recruiting
  • Breast Cancer Stage 2 and 3
  • (no location specified)
Nov 24, 2023

Breast Cancer Trial in Taiwan (Epirubicin+Cyclophosphamide, liposomal-doxorubicin+Cyclophosphamide)

Active, not recruiting
  • Breast Cancer
  • Changhua, Taiwan
  • +8 more
Nov 22, 2021

Concurrent Paclitaxel and Radiotherapy After Adjuvant

Not yet recruiting
  • Breast Cancer
  • Concurrent chemoradiation
  • (no location specified)
Oct 16, 2022

Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Nicosia, Cyprus
  • +1 more
Jul 1, 2022

Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Washington, Baltimore (Simvastatin,

Active, not recruiting
Has Results
  • Breast Cancer
  • +3 more
  • Washington, District of Columbia
  • +1 more
May 19, 2022

Acute Lymphoblastic Leukemia Trial in Memphis (Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Prednisone, Vincristine, Daunorubicin, PEG-L-asparaginase, Erwinia L-asparaginase, Doxorubicin, Cyclophosphamide, Cytarabine, Thioguanine
  • Clofarabine, Methotrexate, Mercaptopurine, Dexamethasone, Etoposide, Dasatinib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jul 26, 2022

Breast Cancer, Chemotherapeutic Toxicity Trial in Hanzhou (Liposomal doxorubicin + Cyclophosphamide vs Docetaxel +

Recruiting
  • Breast Cancer
  • Chemotherapeutic Toxicity
  • Liposomal doxorubicin + Cyclophosphamide vs Docetaxel + Cyclophosphamide
  • Hanzhou, Zhejing, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Apr 7, 2022

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +7 more
  • Portland, Oregon
    SWOG
Sep 27, 2023

HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)

Recruiting
  • HER2-negative Breast Cancer
  • Advanced Solid Tumor
  • Singapore, Singapore
    National University Hospital
Jun 9, 2022

Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Boston (Eribulin, Adriamycin,

Active, not recruiting
Has Results
  • Inflammatory Breast Cancer
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Boston, Massachusetts
  • +1 more
Nov 28, 2022

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Early Stage Breast Cancer Trial in United States (Paclitaxel, Neulasta)

Completed
Has Results
  • Early Stage Breast Cancer
  • Boston, Massachusetts
  • +3 more
Apr 11, 2022

Breast Cancer Trial in New York (Coenzyme Q10, Coenzyme Q10 Placebo)

Completed
  • Breast Cancer
  • New York, New York
    Columbia University Medical Center
Oct 13, 2022

Lymphoma Trial in China (Brentuximab Vedotin, Cyclophosphamide, Doxorubicin)

Not yet recruiting
  • Lymphoma
  • Brentuximab Vedotin
  • +3 more
  • Beijing, China
  • +15 more
Jan 4, 2023

Triple Negative Breast Cancer Trial in Chicago (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
    University of Illinois
Jan 28, 2022

Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)

Completed
Has Results
  • Breast Cancer
  • Cardiac Toxicity
  • trastuzumab
  • +11 more
  • Rochester, Minnesota
    Mayo Clinic Cancer Research Consortium
Jul 12, 2022

PI3Kd Inhibitor, Parsaclisib, CHOP Trial (Parsaclisib, CHOP)

Not yet recruiting
  • PI3Kδ Inhibitor
  • +3 more
  • (no location specified)
Feb 10, 2022

Breast Cancer Trial in Guandong (pegylated liposomal doxorubicin (PLD), cyclophosphamide (C), trastuzumab (H))

Recruiting
  • Breast Cancer
  • pegylated liposomal doxorubicin (PLD)
  • +5 more
  • Guandong, Guangdong, China
    Sunyat-sen Memorial Hospital
Feb 17, 2022